急性移植物抗宿主病是异基因造血干细胞移植后不可避免遇到的棘手问题,临床上主要依靠临床表现及病理活检进行诊断。预测性生物标记物成为近年来研究热点,多中心共同研究成为必然趋势,本文对近年来国内外预测性生物标记物的研究进行总结归纳,主要包括对基因、蛋白质及细胞水平的研究。
Acute graft-versus-host disease (aGVHD) is the primary source of morbidity and mortality after HSCT. Diagnosis of aGVHD is typically based on clinical symptoms and confirmed by biopsy. In this review, we aim to summarize some of the recent developments of biomarkers in the field of al-lo-HSCT, including miRNAs, Cellular biomarkers, Proteomic biomarkers and biomarker panels. At present, the research of biomarkers has become a hotspot. However, predictive biomarkers still require a coordinated multicenter approach with coordinated times of sampling and centralized analysis of biomarker levels.
参考文献ReferencesNassereddine, S., Rafei, H., Elbahesh, E. and Tabbara, I. (2017) Acute Graft versus Host Disease: A Comprehensive Review. Anti-cancer Research, 37, 1547-1555.<br> https://doi.org/10.21873/anticanres.11483Flinn, A.M. and Gennerya, R. (2017) Treatment of Pediatric Acute Graft-versus-Host Disease-Lessons from Primary Immunodeficiency. Frontiers in Immunology, 8, 328. <br> https://doi.org/10.3389/fimmu.2017.00328Yang, J.-Z., Zhang, J.-Q. and Sun, L.-X. (2016) Mechanisms for T Cell Tolerance Induced with Granulocyte Colony-Stimulating Factor. Molecular Immunology, 70, 56-62. <br>https://doi.org/10.1016/j.molimm.2015.12.006王越. 调节性B细胞的免疫调控机制及其在移植物抗宿主病中的作用[J]. 海南医学, 2019, 30(6): 787-791.Xiao, B., Wang, Y., Li, W., et al. (2013) Plasma microRNA Signature as a Noninvasive Biomarker for Acute Graft-versus-Host Disease. Blood, 122, 3365-3375. <br>https://doi.org/10.1182/blood-2013-06-510586Xie, L.N., Zhou, F., Liu, X.M., Fang, Y., Yu, Z., et al. (2014) Serum microRNA155 Is Increased in Patients with Acute Graft-versus-Host Disease. Clinical Transplantation, 28, 314-323. <br>https://doi.org/10.1111/ctr.12314Ranganathan, P., Heaphy, C.E., Costinean, S., Stauffer, N., Na, C., et al. (2012) Regulation of Acute Graft-versus-Host Disease by microRNA-155. Blood, 119, 4786-4797. <br>https://doi.org/10.1182/blood-2011-10-387522Wang, Y., Zhao, X., Ye, X., Luo, H.X., Zhao, T.F., et al. (2015) Plasma microRNA-586 Is a New Biomarker for Acute Graft-versus-Host Disease. Annals of Hematology, 94, 1505-1514. <br>https://doi.org/10.1007/s00277-015-2414-z胡彬, 付伟, 等. 异基因造血干细胞移植后血浆microRNA的表达与急性移植物抗宿主病的相关性研究[J]. 中国实验血液学杂志, 2016, 24(3): 827-832.Zeng, L., Yan, Z., Ding, S., Xu, K. and Wang, L. (2008) Endothelial Injury, an Intriguing Effect of Methotrexate and Cyclophosphamide during Hematopoietic Stem Cell Transplantation in Mice. Transplantation Proceedings, 40, 2670-2673. <br> https://doi.org/10.1016/j.transproceed.2008.06.038Almici, C., Skert, C., Verardi, R., et al. (2014) Changes in Circulating En-dothelial Cells Count Could Become a Valuable Tool in the Diagnostic Definition of Acute Graft-versus-Host Disease. Transplantation, 98, 706-712.
https://doi.org/10.1097/TP.0000000000000385Nakamura, Y., Tanaka, Y., Sugiyama, A., Yamamoto, K., et al. (2016) Soluble Interleukin-2 Receptor Index Predicts the Development of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors. International Journal of Hematology, 103, 436-443. <br>https://doi.org/10.1007/s12185-016-1936-zNelson, R.P., Khawaja, M.R., Perkins, S.M., Elmore, L., et al. (2014) Prognos-tic Biomarkers for Acute Graft-versus-Host Disease Risk after Cyclophosphamide-Fludarabine Nonmyeloablative Allotransplantation. Biology of Blood and Marrow Transplantation, 20, 1861-1864. <br> https://doi.org/10.1016/j.bbmt.2014.06.039唐伦, 颜红菊, 等. 异基因造血干细胞移植患者血清生物标志物水平变化与aGVHD的关系[J]. 中国输血杂志, 2016, 29(6): 598-601.Okamoto, T., Takatsuka, H., Fujimori, Y., Wada, H., Iwasaki, T. and Kakishita, E. (2001) Increased Hepatocyte Growth Factor in Serum in Acute Graft-versus-Host Disease. Bone Marrow Transplant, 28, 197-200.
https://doi.org/10.1038/sj.bmt.1703095Paczesny, S., Krijanovski, O.I., Braun, T.M., et al. (2009) A Biomarker Panel for Acute Graft-versus-Host Disease. Blood, 113, 273-278.Pfundt, R., Wingens, M., Bergers, M., Zweers, M., Frenken, M. and Schalk-wijk, J. (2000) TNF-alpha and Serum Induce SKALP/elafin Gene Expression in Human Keratinocytes by a p38 MAP Ki-nase-Dependent Pathway. Archives of Dermatological Research, 292, 180-187. <br>https://doi.org/10.1007/s004030050475Paczesny, S., Braun, T.M., Levine, J.E., et al. (2010) Elafin Is a Biomarker of Graft-versus-Host Disease of the Skin. Science Translational Medicine, 2, 13ra2. <br>https://doi.org/10.1126/scitranslmed.3000406McDonald, G.B., Tabellini, L., Storer, B.E., Lawler, R.L., Martin, P.J. and Hansen, J.A. (2015) Plasma Biomarkers of Acute GVHD and Nonrelapse Mortality: Predictive Value of Measurements before GVHD Onset and Treatment. Blood, 126, 113-120. <br>https://doi.org/10.1182/blood-2015-03-636753Levine, J.E., Braun, T.M., Harris, A.C., et al. (2015) A Prognostic Score for Acute Graft-versus-Host Disease Based on Biomarkers: A Multicenter Study. The Lancet Haematology, 2, e21-e29.
https://doi.org/10.1016/S2352-3026(14)00035-0Budde, H., Papert, S., Maas, J.-H., Reichardt, H.M., Wulf, G., et al. (2017) Prediction of Graft-versus-Host Disease: A Biomarker Panel Based on Lymphocytes and Cytokines. Annals of Hematology, 96, 1127-1133.Schwinger, W., Weber-Mzell, D., Zois, B., et al. (2006) Immune Reconstitution after Purified Autologous and Al-logeneic Blood Stem Cell Transplantation Compared with Unmanipulated Bone Marrow Transplantation in Children. British Journal of Haematology, 135, 76-84. <br> https://doi.org/10.1111/j.1365-2141.2006.06244.xZou, X., Lin, X., et al. (2016) Donor-Derived Regulatory T Cells Attenuate the Severity of Acute Graft-versus-Host Disease after Cord Blood Transplantation. The Tohoku Journal of Experimental Medicine, 239, 193-202.Tvedt, T.H., Lie, S.A., et al. (2016) Pre-Transplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation. International Journal of Molecular Sciences, 17, 1823.
https://doi.org/10.3390/ijms17111823